key: cord-0987133-vskcnvua
authors: Llamas‐Velasco, M.; Muñoz‐Hernández, P.; Lázaro‐González, J.; Reolid‐Pérez, A.; Abad‐Santamaría, B.; Fraga, J.; Daudén‐Tello, E.
title: Thrombotic occlusive vasculopathy in skin biopsy from a livedoid lesion of a COVID‐19 patient
date: 2020-05-14
journal: Br J Dermatol
DOI: 10.1111/bjd.19222
sha: f687cb9e2cafe78bfafb5cb3316b7853b3bfed26
doc_id: 987133
cord_uid: vskcnvua

Some authors have reported the presence of cutaneous lesions related to new COronaVirus Disease 2019 (CoViD‐19) caused by SARS‐CoV‐2, in up to 20.4% of the cases; however, these lesions are not well characterized either clinically or histopathologically.(1) Recently, it has been highlighted the finding of congested and edematous blood vessels in the alveolar septum along with hyaline thrombi, and also in the heart, liver and kidney of autopsies of 3 patients deceased due to severe infection by SARS‐CoV‐2.

Disease 2019 (CoViD-19) caused by SARS-CoV-2, in up to 20.4% of the cases; however, these lesions are not well characterized either clinically or histopathologically. 1 Recently, it has been highlighted the finding of congested and edematous blood vessels in the alveolar septum along with hyaline thrombi, and also in the heart, liver and kidney of autopsies of 3 patients deceased due to severe infection by SARS-CoV-2. 2 Thus, anticoagulant treatment has been proposed to decrease mortality in certain cases of severe CoViD-19 disease. 3 We report a case of livedoid purple lesions along with acrocyanosis in a patient with confirmed SARS-CoV-2 infection with positive nasopharyngeal swab, showing an underlying obstructive cutaneous vasculopathy and sweat gland necrosis, both previously undescribed findings in this disease.

A 61-year-old male, otherwise apparently healthy except for a history of diabetes, was accepted as an inpatient in the intensive care unit with the diagnosis of COVID-associated severe bilateral pneumonia complicated with diabetic ketoacidosis. Simultaneously started showing cutaneous lesions. There was no previous history of immunosuppression, new drugs or endovascular manipulation. He was treated with low molecular weight heparin.

Physical examination showed purple ischemic digits involving the second and fourth distal phalanges of the right hand, and milder in the second, fourth and fifth digits of the left hand.

Second, third and fifth digits of the left foot were also involved. In addition, we observed livedoid purplish retiform and roundish patches in the other fingertips and in both, volar and dorsal areas of both feet and hands, some with angled edges (Fig 1 a) . No cutaneous or mucosal lesions in other areas were observed.

A biopsy showed a slightly necrotic upper epidermis. In the papillary dermis, dilated blood vessels were found, most of them filled with hyaline thrombi and few with a mild neutrophilic component surrounding them. In some areas, larger arterial vessels located in the dermo-hypodermal interface showed focal fibrinoid necrosis surrounded by a scarce neutrophilic infiltrate (Fig 1b-d) . Orcein staining demonstrated that the larger vessel was an artery. Sweat gland necrosis and degeneration was present, more evident in the secretory portion of the eccrine sweat coil, with preserved eccrine ducts. Microbiological cultures from skin biopsy and blood and PCR for SARS-CoV-2 from the skin biopsy were negative.

This article is protected by copyright. All rights reserved Blood tests showed increased fibrinogen (up to 995 mg/mL) and D-dimer levels (60.83 mg/L) and leucopenia, with later progressive normalization. Coagulation tests showed a heterozygous Factor V Leiden mutation with normal antithrombin III, homocysteine, protein C and protein S levels. No Retiform purpura and livedoid lesions in our patient could be explained as a cutaneous manifestation of an underlying systemic coagulopathy related to COVID-19, as it has been previously described in other coagulopathies. 6 Our patient heterozygous mutation of factor V Leyden is an additional known risk factor favoring thrombosis. 7 Our case´s sweat gland necrosis was similar to the one present in non-drug related coma-associated bulla. 7 But, in our case, thrombi and even fibrinoid necrosis were not only observed in the upper dermis vessels but also in all the other vessels in the biopsy, even in the dermo-hypodermal junction, an unexpected finding that could be related with a more extensive endothelial damage secondary to CoViD-19 infection, as it has been recently reported after observing viral inclusion bodies in electron microscopy of kidney, small bowel and lung of severely affected patients. 8 To our knowledge, this is the first report of a patient with CoViD-19 where the presence of an occlusive vasculopathy at the cutaneous level has been demonstrated. In our case, we observed also a striking sweat gland necrosis, a finding previously reported as associated with ketoacidotic coma but not with CoViD-19 infection. Additional studies are need to completely characterize the tissue damage associated to the virus, including within the gamut of lesions observed in the skin.

Cutaneous manifestations in covid-19: A first perspective

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

COVID-19) infection-induced childblains: a case report with histopahtological findings. JAAD case reports epub 15

Histopathology of cutaneous changes in non-drug-induced

Clinical significance of gene-diagnosis for defects in coagulation factors and inhibitors

Acknowledgments: we would like to thank all the health workers of Hospital Universitario de La Princesa for their extraordinary effort during this pandemic.

This article is protected by copyright. All rights reserved